Colitis

Although a feature in microscopic colitis, gut microbiota dysbiosis was also observed in functional and bile acid diarrhea, indicating fecal microbial changes are not due to the disease itself, researchers noted in BMC Gastroenterology.

The first reported incident of emphysematous cystitis in a patient with severe Crohn’s disease, without UTI or fistulizing disease, may signal “poor prognosis” for these patients, according to a case report published in BMC Gastroenterology.

Though further study is warranted, Leonard B. Weinstock, MD, FACP, adjunct professor at the Washington University School of Medicine, reported promising results of low-dose naltrexone use among two patients with Crohn’s disease.

LAS VEGAS – Flexible sigmoidoscopy with distal colon biopsies was an acceptable initial diagnostic test among patients with suspected immunotherapy-mediated colitis, according to a presentation at the ACG Annual Scientific Meeting.

In this video exclusive, Florian Rieder, MD, and Jiannan Li, MD, PhD, from Cleveland Clinic, discussed a study that looked at Cadherin-11 levels in patients with inflammatory bowel disease, in particular Crohn’s disease.

Entyvio therapy may improve disease course of immune-mediated diarrhea colitis and decrease steroid exposure, according to a presentation at the American College of Gastroenterology virtual annual meeting.”

The Crohn’s and Colitis Foundation issued guidelines for patients with IBD to protect themselves from COVID-19 such as talk with their gastroenterologist about medications, their health status and any precautions they should take related to COVID-19.

The Committee for Medicinal Products for Human Use of the European Medicines Agency recommended approval of the subcutaneous formulation of Entyvio for maintenance therapy in adults with moderately to severely active ulcerative colitis or Crohn’s disease, according to a press release.

AUSTIN, Texas — In this exclusive video from Crohn’s & Colitis Congress, James Lindsay, PhD, FRCP, professor of inflammatory bowel disease at Barts and the London School of Medicine and Dentistry, Queen Mary University of London and a consultant gastroenterologist at Barts Health NHS Trust, discusses positioning therapies in ulcerative colitis.